Zoledronic acid and skeletal-related events in patients with bone metastatic cancer or multiple myeloma

ConclusionsOur study suggests that the ZA use was associated with a decreased risk of SRE for patients with SRE history. However, no preventive effects of ZA were observed for patients without history.
Source: Journal of Bone and Mineral Metabolism - Category: Orthopaedics Source Type: research